StreetAlpha
13F holdings · Q3 2026

Pfizer

New York, NY · files as Pfizer Inc
Know the moment Pfizer filesYou follow Pfizer An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 12, 2026Next filing due Feb 15, 2027CIK 78003

Pfizer reported 17 stocks worth $164M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are ALLO (22.1%), ARVN (16.0%) and CELC (14.3%). Compared with Q2 2026, the fund opened new positions in WVE and SENS, added to AGMB and sold out of WVE and SENS.

Latest filing: what Pfizer did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
2 new1 added0 trimmed2 sold outBought about $28.9M · sold about $10.9M
New 2
Added 1
Trimmed 0

None

Sold out 2

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$164M−3.6% vs last quarter
Stocks held172 new · 2 sold out
Top 5 weight78.4%very concentrated
Turnover24%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
ALLO
Allogene Therapeutics Inc
$36.4M22.1%22MNo change8 of 8
2
ARVN
Arvinas Inc
$26.2M16.0%3.5MNo change8 of 8
3
CELC
Celcuity Inc
$23.5M14.3%296KNo change8 of 8
4
AGMB
Agomab Therapeutics NV
$22.6M13.8%2.2M+2.1M (+2768%)3 of 8
5
PYXS
Pyxis Oncology Inc
$20.1M12.3%7MNo change8 of 8
6
WVE
Wave Life Sciences Inc.
$7.1M4.3%1.9MNew position1 of 8
7
BHVN
Biohaven Ltd
$6.6M4.0%506KNo change8 of 8
8
CRBU
Caribou Biosciences Inc
$5.8M3.5%4.7MNo change8 of 8
9
ORIC
Oric Pharmaceuticals Inc
$4.9M3.0%373KNo change8 of 8
10
CRDF
Cardiff Oncology Inc
$3M1.8%2.4MNo change8 of 8
🔒 7 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
WVE
Wave Life Sciences Ltd
$10.9M1.9M
SENS
Senseonics Holdings
$12K2,171

Reported value

last 8 quarters
$2.6BQ4 '24
$501MQ1 '25
$576MQ2 '25
$437MQ3 '25
$236MQ4 '25
$239MQ1 '26
$170MQ2 '26
$164MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 12, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Pfizer 13F FAQ

What does Pfizer own?

Pfizer reported 17 stocks worth $164M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are ALLO (22.1%), ARVN (16.0%) and CELC (14.3%). The table above lists every position in the filing (the top 10 without an account).

What did Pfizer buy and sell in Q3 2026?

Compared with Q2 2026: 2 new positions, 1 added to, 0 trimmed and 2 sold out. New positions include WVE and SENS. It sold all of WVE and SENS.

When will Pfizer file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Pfizer's portfolio worth?

The Q3 2026 filing reports $164M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.